Triple-negative breast cancer (TNBC), which lacks oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for approximately 15–20% of all BCs. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.